{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:28:34Z","timestamp":1774744114761,"version":"3.50.1"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1093\/ndt\/gft027","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T03:35:29Z","timestamp":1362800129000},"page":"1994-2002","source":"Crossref","is-referenced-by-count":35,"title":["Impaired platelet P2Y12 inhibition by thienopyridines in chronic kidney disease: mechanisms, clinical relevance and pharmacological options"],"prefix":"10.1093","volume":"28","author":[{"given":"Olivier","family":"Morel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clotilde","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Jesel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Hannedouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"key\n\t\t\t\t20170518091003_GFT027C1","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.jacc.2011.06.056","article-title":"Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database","volume":"58","author":"Tsai","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcin.2008.06.012","article-title":"In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry","volume":"2","author":"Latif","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20170518091003_GFT027C3","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/01.CIR.0000103623.63687.21","article-title":"Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction","volume":"108","author":"Sadeghi","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170518091003_GFT027C4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jacc.2007.04.051","article-title":"Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry","volume":"50","author":"Machecourt","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2008.11.138","article-title":"Renal function and drug-eluting stent","volume":"142","author":"Briguori","year":"2010","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C6","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","article-title":"The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions","volume":"39","author":"Best","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/CIRCULATIONAHA.110.974683","article-title":"Ticagrelor in the renal dysfunction subgroup: subjugated or substantiated?","volume":"122","author":"Montalescot","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170518091003_GFT027C8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jacc.2010.09.032","article-title":"Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel","volume":"57","author":"Morel","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1681\/ASN.2010020220","article-title":"Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention","volume":"22","author":"Htun","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.109.933796","article-title":"Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"122","author":"James","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170518091003_GFT027C11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0272-6386(96)90358-3","article-title":"Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors","volume":"27","author":"Sreedhara","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518091003_GFT027C12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1681\/ASN.V5136","article-title":"Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease","volume":"5","author":"Gawaz","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C13","first-page":"823","article-title":"Abnormal cytoskeletal assembly in platelets from uremic patients","volume":"143","author":"Escolar","year":"1993","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ki.1993.264","article-title":"Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension","volume":"44","author":"Noris","year":"1993","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518091003_GFT027C15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cardiores.2006.09.019","article-title":"Platelet nitric oxide synthesis in uremia and malnutrition: a role for L-arginine supplementation in vascular protection?","volume":"73","author":"Brunini","year":"2007","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170518091003_GFT027C16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajh.2830350306","article-title":"Selective reduction of serotonin storage and ATP release in chronic renal failure patients platelets","volume":"35","author":"Soslau","year":"1990","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.thromres.2006.02.013","article-title":"The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients","volume":"119","author":"Brophy","year":"2007","journal-title":"Thromb Res"},{"key":"key\n\t\t\t\t20170518091003_GFT027C18","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1538-7836.2004.00837.x","article-title":"Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia","volume":"2","author":"Bonomini","year":"2004","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20170518091003_GFT027C19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/ATVBAHA.109.200956","article-title":"Cellular mechanisms underlying the formation of circulating microparticles","volume":"31","author":"Morel","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C20","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ahj.2011.09.003","article-title":"Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: Results of the Effect of Platelet Inhibition According to Clopidogrel Dose in Patients with Chronic Kidney Disease (PIANO-2 CKD) randomized study","volume":"162","author":"Woo","year":"2011","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170518091003_GFT027C21","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1681\/ASN.2005050535","article-title":"Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure","volume":"16","author":"Amabile","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C22","first-page":"325","article-title":"Mild-to-moderate renal impairment is associated with platelet activation: a cross-sectional study","volume":"70","author":"Thijs","year":"2008","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/09537100412331272569","article-title":"Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation","volume":"16","author":"Ballow","year":"2005","journal-title":"Platelets"},{"key":"key\n\t\t\t\t20170518091003_GFT027C24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.thj.6200153","article-title":"Plasma thrombopoietin levels in patients with chronic renal failure","volume":"3","author":"Linthorst","year":"2002","journal-title":"Hematol J"},{"key":"key\n\t\t\t\t20170518091003_GFT027C25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ahj.2007.10.046","article-title":"The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial","volume":"155","author":"Best","year":"2008","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170518091003_GFT027C26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.amjcard.2009.01.342","article-title":"Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial)","volume":"103","author":"Dasgupta","year":"2009","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00044011-199816040-00006","article-title":"Clopidogrel activities in patients with renal function impairment","volume":"16","author":"Deray","year":"1998","journal-title":"Clin Drug Investig"},{"key":"key\n\t\t\t\t20170518091003_GFT027C28","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1016\/j.thromres.2010.08.009","article-title":"Lack of effect of chronic kidney disease on clopidogrel response with high loading and maintenance doses of clopidogrel after Acute Coronary Syndrome","volume":"126","author":"Cuisset","year":"2010","journal-title":"Thromb Res"},{"key":"key\n\t\t\t\t20170518091003_GFT027C29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1018758308979","article-title":"A pharmacodynamic study of clopidogrel in chronic hemodialysis patients","volume":"10","author":"Kaufman","year":"2000","journal-title":"J Thromb Thrombolysis"},{"key":"key\n\t\t\t\t20170518091003_GFT027C30","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.amjcard.2009.06.049","article-title":"A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure","volume":"104","author":"Park","year":"2009","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C31","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jacc.2009.10.043","article-title":"Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy","volume":"55","author":"Angiolillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C32","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.2337\/diacare.28.10.2436","article-title":"Glycemic status and development of kidney disease: the Framingham Heart Study","volume":"28","author":"Fox","year":"2005","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20170518091003_GFT027C33","doi-asserted-by":"crossref","first-page":"27A","DOI":"10.1016\/j.amjcard.2008.11.020","article-title":"Variability in responsiveness to oral antiplatelet therapy","volume":"103","author":"Angiolillo","year":"2009","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.atherosclerosis.2011.03.039","article-title":"Impaired inhibition of P2Y(12) by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention","volume":"217","author":"El Ghannudi","year":"2011","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170518091003_GFT027C35","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/j.ajkd.2011.12.027","article-title":"Association of estimated GFR with platelet inhibition in patients treated with clopidogrel","volume":"59","author":"Muller","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518091003_GFT027C36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1538-7836.2004.01063.x","article-title":"Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases","volume":"3","author":"Aleil","year":"2005","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20170518091003_GFT027C37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1538-7836.2007.02812.x","article-title":"The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score","volume":"6","author":"Geisler","year":"2008","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20170518091003_GFT027C38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/clpt.2009.163","article-title":"The influence of chronic renal failure on drug metabolism and transport","volume":"86","author":"Dreisbach","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170518091003_GFT027C39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1515\/CCLM.2011.004","article-title":"Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis","volume":"49","author":"Gugliucci","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"key\n\t\t\t\t20170518091003_GFT027C40","first-page":"1214","article-title":"The effect of renal failure on hepatic drug clearance","volume":"25","author":"Touchette","year":"1991","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20170518091003_GFT027C41","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1681\/ASN.V122326","article-title":"Downregulation of hepatic cytochrome P450 in chronic renal failure","volume":"12","author":"Leblond","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2710.2009.01068.x","article-title":"Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease","volume":"34","author":"Small","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"key\n\t\t\t\t20170518091003_GFT027C43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1525-139X.2009.00588.x","article-title":"Dinucleoside polyphosphates and uremia","volume":"22","author":"Jankowski","year":"2009","journal-title":"Semin Dial"},{"key":"key\n\t\t\t\t20170518091003_GFT027C44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.thromres.2009.11.006","article-title":"Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptors","volume":"125","author":"Chang","year":"2010","journal-title":"Thromb Res"},{"key":"key\n\t\t\t\t20170518091003_GFT027C45","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1046\/j.1523-1755.2001.0590031134.x","article-title":"Increased vascular growth in hemodialysis patients induced by platelet-derived diadenosine polyphosphates","volume":"59","author":"Jankowski","year":"2001","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518091003_GFT027C46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.hjr.0000220582.19516.a6","article-title":"Renal function and outcomes in acute coronary syndrome: impact of clopidogrel","volume":"14","author":"Keltai","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"key\n\t\t\t\t20170518091003_GFT027C47","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jacc.2008.05.054","article-title":"Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel","volume":"52","author":"Ang","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C48","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00392-010-0179-x","article-title":"Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions","volume":"99","author":"Geisler","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1160\/TH11-12-0876","article-title":"The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: Roles of white blood cell count and body weight","volume":"108","author":"Morel","year":"2012","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20170518091003_GFT027C50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/09537100020031207","article-title":"Platelet CD40 ligand (CD40L)\u2013subcellular localization, regulation of expression, and inhibition by clopidogrel","volume":"12","author":"Hermann","year":"2001","journal-title":"Platelets"},{"key":"key\n\t\t\t\t20170518091003_GFT027C51","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2337\/diabetes.55.03.06.db05-1394","article-title":"Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease","volume":"55","author":"Angiolillo","year":"2006","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170518091003_GFT027C52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00395-009-0073-8","article-title":"Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes","volume":"105","author":"Diehl","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C53","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/01.STR.0000124122.71702.64","article-title":"Leukocyte count as an independent predictor of recurrent ischemic events","volume":"35","author":"Grau","year":"2004","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20170518091003_GFT027C54","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/eurheartj\/ehn112","article-title":"Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy","volume":"29","author":"O'Donoghue","year":"2008","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170518091003_GFT027C55","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","article-title":"Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial","volume":"49","author":"Bhatt","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C56","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/hrt.2010.210419","article-title":"High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial","volume":"97","author":"Weber","year":"2011","journal-title":"Heart"},{"key":"key\n\t\t\t\t20170518091003_GFT027C57","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/eurheartj\/ehl489","article-title":"A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days","volume":"28","author":"von Beckerath","year":"2007","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170518091003_GFT027C58","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170518091003_GFT027C59","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","article-title":"A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents: Results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) Study","volume":"59","author":"Trenk","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C60","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518091003_GFT027C61","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(08)60422-5","article-title":"Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial","volume":"371","author":"Wiviott","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170518091003_GFT027C62","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","article-title":"Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170518091003_GFT027C63","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1111\/j.1538-7836.2011.04531.x","article-title":"Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on-treatment platelet reactivity","volume":"9","author":"Alexopoulos","year":"2011","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20170518091003_GFT027C64","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/CIRCULATIONAHA.109.919456","article-title":"Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study","volume":"121","author":"Gurbel","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170518091003_GFT027C65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2012.03.050","article-title":"Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study","volume":"60","author":"Alexopoulos","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170518091003_GFT027C66","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518091003_GFT027C67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1755-5922.2009.00096.x","article-title":"Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist","volume":"27","author":"Husted","year":"2009","journal-title":"Cardiovasc Ther"},{"key":"key\n\t\t\t\t20170518091003_GFT027C68","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/j.ajkd.2012.05.001","article-title":"Ticagrelor in clopidogrel-resistant patients undergoing maintenance hemodialysis","volume":"60","author":"Alexopoulos","year":"2012","journal-title":"Am J Kidney Dis"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/28\/8\/1994\/12888686\/gft027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T18:03:04Z","timestamp":1644516184000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gft027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,8]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,3,8]]},"published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gft027","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,8]]}}}